AVASCULAR NECROSIS MARKET ANALYSIS

Avascular Necrosis Market, by Drug Type (Non-steroidal anti-inflammatory drugs (Ibuprofen, and Naproxen Sodium), Osteoporosis drugs, Cholesterol-lowering drugs, Blood Thinners, and Others), by Route of Administration (Oral, Injectable), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028

Published In : Dec 2021
Code : CMI2218
Pages :147
Formats :
Excel and PDF
Industry : Pharmaceutical

Regional Analysis

Global Avascular Necrosis Market – Regional Analysis

On the basis of region, the global avascular necrosis market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

North America is expected to hold a dominant position in the global avascular necrosis market, owing to increasing number of inorganic growth strategies by market key players.

For instance, in April 2021, ECI Pharmaceuticals, LLC, a pharmaceutical company announced that it had entered into a distribution agreement with AiPing Pharmaceuticals, Inc., a pharmaceutical company, to manage the sales, marketing, and distribution of Ibuprofen 400 mg, 600 mg, 800 mg tablets, and Folic Acid 1 mg tablets in the U.S.

Geographies covered:

North America: U.S. and Canada
Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
Middle East: GCC, Israel, and Rest of Middle East
Africa: South Africa, North Africa, and Central Africa